Question Quinolones Based on Updated Warnings

Stronger warnings will lead to more concerns about quinolone risks.

Quinolone labels already caution about hypo- and hyperglycemia...and certain CNS effects such as agitation, nervousness, or confusion.

Now FDA will require warnings of hypoglycemic coma...especially in the elderly, renal impairment, or in combo with insulin or a sulfonylurea.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote